Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: A review

Biomarkers

Volumn 11, Issue 5, 2006, Pages 406-416

  Downes, M R ^a   Byrne, J C ^a   Dunn, M J ^a   Fitzpatrick, J M ^a   Watson, R W G ^a   Pennington, S R ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Biomarker; Prostate cancer; Proteomics; Urine

Indexed keywords

BIOCHEMICAL MARKER; CALGRANULIN; TRANSFERRIN;

GENOMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; ISOELECTRIC FOCUSING; ISOTOPE ANALYSIS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROGNOSIS; PROSTATE CANCER; PROTEIN URINE LEVEL; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TRANSCRIPTOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINALYSIS; WESTERN BLOTTING; WESTERN HEMISPHERE;

HUMANS; MALE; PROSTATIC NEOPLASMS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748539021     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500600799821     Document Type: Review

References (42)

1. Applied Biosystems. 2005a. Cleavable ICAT reagents data sheet(available at: http://www.appliedbiosystems.com) (accessed on 19 December 2005).
2. Applied Biosystems. 2005b. ITRAQ reagents product bulletin(available at: http://www.appliedbiosystems.com) (accessed on 19 December 2005).
3. Barker CR, Hamlett J, Pennington SR, Burrows F, Lundgren K, Watson AJ, Jenkins JR. 2006. The topoisomerase II and Hsp90 interaction: A new chemotherapeutic target? International Journal of Cancer 118:2685-2693.
4. Bradley, EB and Bissonnette, EA and Theodorescu, D. (2004) Determinants of long term quality of life and voiding function of patients treated with radical prostatectomy or permanent brachytherapy for prostate cancer British Journal of Urology International, 94, pp. 1003-1009.
5. Charaund, P and Caprioloi, RM. (2002) Direct profiling and imaging of peptides and proteins from mammalian cells and tissue sections by mass spectrometry Electrophoresis, 23, pp. 3125-3135.
6. Clauser, KR and Baker, P and Burlingame, AL. (1999) Role of accurate mass measurement (+/- 10 ppm) in protein identification strategies employing MS or MS/MS and database searching Analytical Chemistry, 71, pp. 2871-2882.
7. Conrads, TP and Zhou, M and Petricoin, EF and Liotta, L and Veenstra, TD. (2003) Cancer diagnosis using proteomic patterns Expert Reviews in Molecular Diagnosis, 3, pp. 411-420.
8. Cutillas, PR and Ckalkley, RJ and Hansen, KC and Cramer, R and Norden, AG and Waterfield, MD and Burlingame, AL and Unwin, RJ. (2004) The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells American Journal of Physiology and Renal Physiology, 287, pp. 353-364.
9. Duncan, R and McConkey, EH. (1982) How many proteins are there in the mammalian cell? Clinical Chemistry, 28, pp. 749-755.
10. Fenn, JB and Mann, M and Meng, CK and (1989) Electrospray ionisation for mass spectrometry of large biomolecules Science, 246, pp. 64-71.
11. Fernandez, C and Rifai, N and Wenger, AS and (1986) A preliminary study of urinary transferrin as a marker for prostate cancer Clinica et Chimica Acta, 161, pp. 335-339.
12. Freedland, SJ and Humphreys, EB and Mangold, LA and Eisenberger, M and Dorey, FD and Walsh, PC and Partin, AW. (2005) Risk of prostate cancer specific mortality following biochemical recurrence after radical prostatectomy Journal of the American Medical Association, 294, pp. 433-439.
13. Fung, KYC and Globe, LM and Green, S and (2004) A comprehensive characterization of the peptide and protein constituents of human seminal fluid Prostate, 61, pp. 171-181.
14. Gorg, A and Weiss, W and Dunn, MJ. (2004) Current two-dimensional electrophoresis technology for proteomics Proteomics, 4, pp. 3665-3685.
15. Grover, PK and Resnick, MI. (1997) High resolution two dimensional electrophoresis analysis of urinary proteins of patients with prostate cancer Electrophoresis, 18, pp. 814-818.
16. Hirsch, J and Hansen, KC and Burlingame, AL. (2004) Proteomics: Current techniques and potential applications to lung disease American Journal of Physiology: Lung Cellular and Molecular Physiology, 287, pp. 1-23.
17. Jenkins RE, Kitteringham NR, Hunter CL, Webb SN, Hunt TJ, Elsby R, Watson RB, Williams D, Pennington SR, Park K. 2005. Relative and absolute quantitative expression profiling of cytochromes P450 using isotope coded affinity tags. Proteomics 6:1934-1947.
18. Jurcevic, S and Ainsworth, ME and Pomerance, A and Smith, JD and Robinson, DR and Dunn, MJ and Yacoub, MH and Rose, ML. (2001) Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation Transplantation, 71, pp. 886-892.
19. Karas, M and Hillenkamp, F. (1988) Laser desorption ionisation of proteins with molecular masses exceeding 10,000 Da Analytical Chemistry, 60, pp. 2299-2301.
20. Kuruma, H and Egawa, S and Oh-Ishi, M and (2005) Proteome analysis of prostate cancer Prostate Cancer and Prostatic Diseases, 8, pp. 14-21.
21. Mann, M and Jensen, ON. (2003) Proteomic analysis of post-translational modifications National Biotechnology, 21, pp. 255-261.
22. Medzihradszky, KF and Campbell, JM and Baldwin, MA and (2000) The characteristics of peptide collision-induced dissociation using a high performance MALDI-TOF-TOF tandem mass spectrometer Analytical Chemistry, 72, pp. 552-558.
23. Merchant, M and Weinberger, SR. (2000) Recent advancements in SELDI-TOF-MS Electrophoresis, 21, pp. 1164-1177.
24. Mischak, H and Kaiser, T and Walder, M and (2004) Proteomic analysis for the assessment of diabetic renal damage in humans Clinical Science, 107, pp. 485-495.
25. Norden, AG and Sharratt, P and Cutillas, PR and (2004) Quantitative amino acid and proteomic analysis: Very low excretion of polypeptides > 750 Da in normal urine Kidney International, 66, pp. 1994-2003.
26. Norden, AGW and Scheinman, SJ and Deschodt-Lanckman, MM and (2000) Tubular proteinuria defined by a study of Dents and other tubular diseases Kidney International, 57, pp. 240-249.
27. O'Farrell, PH. (1975) High resolution two-dimensional electrophoresis of proteins Journal of Biology and Chemistry, 250, pp. 4007-4021.
28. Oh, J and Pyo, JH and Jo, EH and (2004) Establishment of a near standard two dimensional human urine proteomic map Proteomics, 4, pp. 3485-3497.
29. Pennington, SR and Dunn, MJ. (2003a) Adding value in the target discovery and drug development pipeline (Part 1) European Pharmacology Review Issue, 1, pp. 31-34.
30. Pennington, SR and Dunn, MJ. (2003b) Adding value in the target discovery and drug development pipeline (Part 2) European Pharmacology Review Issue, 2, pp. 16-19.
31. Pieper, R and Gatlin, CL and McGrath, AM and (2004) Characterization of the human urinary proteome: A method for high resolution display of urinary proteins on two dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots Proteomics, 4, pp. 1159-1174.
32. Rehman, I and Azzouzi, R and Catto, WF and (2004) Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study Journal of Urology, 64, pp. 1238-1243.
33. Rogers, MA and Clarke, P and Noble, J and (2003) Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionisation and neural network analysis: Identification of key issues affecting potential clinical utility Cancer Research, 63, pp. 6971-6983.
34. Schaub, S and Rush, D and Wilkins, J and (2004b) Proteomic based detection of urine proteins associated with acute renal allograft rejection Journal of the American Society of Nephrology, 15, pp. 219-227.
35. Schaub, S and Wilkins, J and Weiler, T and (2004a) Urine protein profiling with surface enhanced laser-desorption/ionisation time of flight mass spectrometry Kidney International, 65, pp. 323-332.
36. Schaub, S and Wilkins, JA and Antonovici, M and (2005) Proteomic based identification of cleaved urinary B2 microglobulin as a potential marker for acute tubular injury in renal allografts American Journal of Transplantation, 5, pp. 729-738.
37. Sharma, K and Lee, SH and Han, S and (2005) Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy Proteomics, 5, pp. 2648-2655.
38. Shekouh, AR and Thompson, CC and Prime, W and Campbell, F and Hamlett, J and Herrington, CS and Lemoine, NR and Buechler, MW and Friess, H and Neoptolemo, JP and Pennington, SR and Costello, E. (2003) Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma Proteomics, 3, pp. 1988-2001.
39. The National Cancer Registry Ireland. 2001. Incidence, mortality, treatment and survival 1994-2001(available at: http://www.ncri.ie) (accessed on 12 January 2006).
40. The United Kingdom National Statistics. 2003. Mortality statistics for 2003(available at: http://www.statistics.gov.uk) (accessed on 12 January 2006).
41. Thongboonkerd, V and McLeish, KR and Arthur, JM and (2002) Proteomic analysis of normal human urinary proteins isolated by acetone precipitation or ultracentrifugation Kidney International, 62, pp. 1462-1469.
42. Wittke, S and Fliser, D and Herbitz, M and (2003) Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers Journal of Chromatography, A 1013, pp. 173-181.